Study Group: Flonase Prescribers(?)

The use of long-acting beta-agonists (LABAs) in the treatment of persistent asthma has become one of the most controversial issues of respiratory disease management during this decade. Both salmeterol and formoterol have been shown in numerous clinical trials of asthma to dramatically improve pulmonary...

This recent report characterizes a newly discovered anti-IgE monoclonal antibody (mAb12) which appears dramatically more potent than omalizumab (Xolair) in its ability to reduce systemic IgE levels. If further studies confirm this enhanced reduction of IgE and IgE-bearing cells, mAb12 has significant...

Symbicort is AstraZeneca's answer to Advair, presently the number one combination ICS/LABA in the U.S. for treating moderate to severe asthma. Symbicort will not, however, have an indication for quick relief of bronchospasm as it does in many European countries. Nevertheless, Symbicort appears to be...

With the likely pandemic viral event looming on the horizon, the ability to place strategic, distributed quantities would allow for a better medical response, most likely will help to avert panic hording, and allow more rural and diverse early intervention.

As pointed out by prior analysis this article looked at patient purchasing behavior when costs of certain health care are 'out of pocket', in this case LASIK eye surgery.  Instead of price-shopping or somehow looking for most experienced or a higher-quality doctor, consumers seem to be motivated...